Terms: = Pancreatic cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
272 results:
1. Vitamin Nutritional Status in Patients with pancreatic cancer: A Narrative Review.
Azzini E; Furini T; Polito A; Scalfi L; Pinto A; Gasperi V; Savini I; On Behalf Of The Sinu Nutrition In Oncology Working Group
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732007
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer.
Sun L; Wang J; Li Y; Kang Y; Jiang Y; Zhang J; Qian S; Xu F
BMC Cancer; 2024 May; 24(1):567. PubMed ID: 38711020
[TBL] [Abstract] [Full Text] [Related]
3. Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma.
Rupp L; Dietsche I; Kießler M; Sommer U; Muckenhuber A; Steiger K; van Eijck CWF; Richter L; Istvanffy R; Jäger C; Friess H; van Eijck CHJ; Demir IE; Reyes CM; Schmitz M
Front Immunol; 2024; 15():1378190. PubMed ID: 38629072
[TBL] [Abstract] [Full Text] [Related]
4. Decoding the Versatile Landscape of Autophagic Protein VMP1 in cancer: A Comprehensive Review across Tissue Types and Regulatory Mechanisms.
Renna FJ; Gonzalez CD; Vaccaro MI
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612567
[TBL] [Abstract] [Full Text] [Related]
5. [A Case of Preoperative Chemotherapy for Advanced Gastric cancer, Laparoscopic Total Gastrectomy, pancreaticoduodenectomy, and Para-Aortic Lymph Node Dissection].
Fukuda K; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Ikenaga M; Kawase T; Shimizu J; Imamura H; Dono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1438-1440. PubMed ID: 38303300
[TBL] [Abstract] [Full Text] [Related]
6. Therapy-induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression.
Abu-Humaidan AH; Ismail MA; Ahmad FM; Al Shboul S; Barham R; Tadros JS; Alhesa A; El-Sadoni M; Alotaibi MR; Ababneh NA; Saleh T
Immunol Cell Biol; 2024 Apr; 102(4):240-255. PubMed ID: 38265162
[TBL] [Abstract] [Full Text] [Related]
7. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
[TBL] [Abstract] [Full Text] [Related]
8. Repurposing of Strychnine as the Potential Inhibitors of Aldo-keto Reductase Family 1 Members B1 and B10: Computational Modeling and Pharmacokinetic Analysis.
Sarfraz M; Aziz M; Afzal S; Channar PA; Alsfouk BA; Kandhro GA; Hassan S; Sultan A; Hamad A; Arafat M; Qaiser MN; Ahmed A; Siddique F; Ejaz SA
Protein J; 2024 Apr; 43(2):207-224. PubMed ID: 37940790
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
10. Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-box
Zhang H; Xia P; Yang Z; Liu J; Zhu Y; Huang Z; Zhang Z; Yuan Y
Clin Transl Med; 2023 Oct; 13(10):e1443. PubMed ID: 37837399
[TBL] [Abstract] [Full Text] [Related]
11. Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer.
Xia L; Nie T; Lu F; Huang L; Shi X; Ren D; Lu J; Li X; Xu T; Cui B; Wang Q; Gao G; Yang Q
Autophagy; 2024 Mar; 20(3):505-524. PubMed ID: 37772772
[TBL] [Abstract] [Full Text] [Related]
12. Hydrogen Peroxide Mediates Pharmacological Ascorbate Induced Radio-Sensitization of pancreatic cancer Cells by Enhancing G2-accumulation and Reducing Cyclin B1 Protein Levels.
O'Leary BR; Kalen AL; Pope AN; Goswami PC; Cullen JJ
Radiat Res; 2023 Nov; 200(5):444-455. PubMed ID: 37758045
[TBL] [Abstract] [Full Text] [Related]
13. Chronic expanding hematoma of the liver: a case report and review of the literature.
Shimagaki T; Sugimachi K; Mano Y; Tomino T; Onishi E; Taguchi K; Morita M; Toh Y
Clin J Gastroenterol; 2024 Feb; 17(1):93-99. PubMed ID: 37751079
[TBL] [Abstract] [Full Text] [Related]
14. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
Chen Q; Fu Y; Liu X; Wang P; Dai S; Zhu F; Liu T; Xu W; Wu J
Mol Carcinog; 2023 Dec; 62(12):1947-1959. PubMed ID: 37642304
[TBL] [Abstract] [Full Text] [Related]
15. High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma.
Zhou Y; Gu Q; Zhu L; Zhang S; Wu H; Pu X; Jiang C; Chen J
Cell Prolif; 2023 Dec; 56(12):e13513. PubMed ID: 37401015
[TBL] [Abstract] [Full Text] [Related]
16. Role of Immune Microenvironment in pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?
De Simoni O; Dal Santo L; Scarpa M; Munari G; Spolverato YC; Scapinello A; Lonardi S; Soldà C; Bergamo F; Fantin A; Bardini R; Pilati P; Fassan M; Gruppo M
Curr Oncol; 2023 Jun; 30(6):5515-5528. PubMed ID: 37366900
[TBL] [Abstract] [Full Text] [Related]
17. MHC class I loss is associated with biliary/progenitor cell features and "cold" tumor-immune microenvironment in hepatocellular carcinoma.
Shigematsu Y; Amori G; Tanaka K; Kitahama K; Kanda H; Takahashi Y; Takazawa Y; Takeuchi K; Inamura K
Virchows Arch; 2023 Aug; 483(2):177-186. PubMed ID: 37306724
[TBL] [Abstract] [Full Text] [Related]
18. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
19. Safety and efficacy of vitamin B in cancer treatments: A systematic review.
Van de Roovaart HJ; Stevens MM; Goodridge AE; Baden KR; Sibbitt BG; Delaney E; Haluschak J; Kathula S; Chen AMH
J Oncol Pharm Pract; 2024 Apr; 30(3):451-463. PubMed ID: 37231628
[TBL] [Abstract] [Full Text] [Related]
20. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.
Kotsiliti E; Leone V; Schuehle S; Govaere O; Li H; Wolf MJ; Horvatic H; Bierwirth S; Hundertmark J; Inverso D; Zizmare L; Sarusi-Portuguez A; Gupta R; O'Connor T; Giannou AD; Shiri AM; Schlesinger Y; Beccaria MG; Rennert C; Pfister D; Öllinger R; Gadjalova I; Ramadori P; Rahbari M; Rahbari N; Healy ME; Fernández-Vaquero M; Yahoo N; Janzen J; Singh I; Fan C; Liu X; Rau M; Feuchtenberger M; Schwaneck E; Wallace SJ; Cockell S; Wilson-Kanamori J; Ramachandran P; Kho C; Kendall TJ; Leblond AL; Keppler SJ; Bielecki P; Steiger K; Hofmann M; Rippe K; Zitzelsberger H; Weber A; Malek N; Luedde T; Vucur M; Augustin HG; Flavell R; Parnas O; Rad R; Pabst O; Henderson NC; Huber S; Macpherson A; Knolle P; Claassen M; Geier A; Trautwein C; Unger K; Elinav E; Waisman A; Abdullah Z; Haller D; Tacke F; Anstee QM; Heikenwalder M
J Hepatol; 2023 Aug; 79(2):296-313. PubMed ID: 37224925
[TBL] [Abstract] [Full Text] [Related]
[Next]